Clinical Pharmacy

Posts that discuss a wide range of pharmacy topics with clinical knowledge, references, and experience included!

Members only

Clinical Pharmacy

AHA/ACC 2026 Acute PE Guidelines: What You Need to Know

Clinical Pharmacy

The Anti-Smoking Antidepressant

Bupropion’s dopamine and norepinephrine effects reduce nicotine cravings, explaining its FDA approval as a first-line smoking cessation aid now.

Members only

Clinical Pharmacy

ACLS Pharmacotherapy Review: Part 2

Members only

Clinical Pharmacy

Awiqli and the Future of Basal Insulin

Members only

Clinical Pharmacy

OASIS-4 Journal Club

Journal club review of the OASIS-4 trial evaluating oral semaglutide 25 mg for weight loss, including efficacy, safety outcomes, and clinical impact.

Clinical Pharmacy

Hypervolemic Hyponatremia

Hyponatremia in hypervolemic patients explained: risks in older adults, safe sodium correction, and treatment options including loop diuretics and vaptans.

Clinical Pharmacy

The Andexxa Paradox

Andexxa withdrawn after ANNEXA-I showed higher stroke risk; clinicians return to 4F-PCC for DOAC reversal while new agents emerge.

Members only

Clinical Pharmacy

ACLS Pharmacotherapy Review: Part 1

Clinical Pharmacy

2026 GOLD Report Updates

Discover what’s new in the 2026 GOLD COPD Report including earlier detection, new risk definitions, treatment updates, and emerging tech shaping patient care.

Members only

Clinical Pharmacy

Let's Talk Daptomycin

Clinical Pharmacy

DeLLphi-304 Journal Club

Compared to chemotherapy, tarlatamab showcased improved efficacy and safety following progression on or after platinum-based therapies.

Clinical Pharmacy

Potassium and Hypertension

Increasing potassium intake lowers blood pressure, reduces stroke risk, and may decrease antihypertensive medication needs.

Clinical Pharmacy

Essential Thrombocythemia

Essential thrombocythemia (ET) is a chronic BCR::ABL1-negative myeloproliferative neoplasm (MPN) defined by sustained thrombocytosis due to clonal megakaryocyte proliferation.

Clinical Pharmacy

Parkinson’s vs. Parkinsonism: Pharmacotherapy

Accurate differentiation between Parkinson’s disease and other parkinsonian syndromes is key to guiding pharmacotherapy and optimizing patient outcomes.

Members only

Clinical Pharmacy

Updates in the 2025 ATS Community-Acquired Pneumonia Guidelines

Clinical Pharmacy

Myelofibrosis

Myelofibrosis (MF) is a chronic BCR::ABL1-negative myeloproliferative neoplasm (MPN) characterized by clonal myeloid proliferation, bone marrow fibrosis, extramedullary hematopoiesis, and progressive cytopenias.

Clinical Pharmacy

IMforte Journal Club

Overall, this trial was well-designed and provides promising evidence of OS and PFS benefit for patients with extensive-stage SCLC, a historically aggressive disease with poor outcomes

Clinical Pharmacy

Updates in the 2025 ACC/AHA Hypertension Guidelines

The 2025 ACC/AHA hypertension guidelines emphasize earlier detection, lifestyle changes, new PREVENT™ risk tool, and team-based care.

Clinical Pharmacy

Polycythemia Vera

Polycythemia vera (PV) is a Philadelphia chromosome-negative (Ph-) myeloproliferative neoplasm (MPN) characterized by JAK-STAT pathway activation and trilineage myeloproliferation with a predominant increase in red blood cell mass.

Members only

Clinical Pharmacy Featured

Direct Oral Anticoagulant Transitions & Periprocedural Management

Clinical Pharmacy

Corticosteroids: To Taper or Not to Taper

Clinical judgment appears especially crucial when evaluating a patient’s risk of glucocorticoid-induced adrenal insufficiency

Members only

Clinical Pharmacy

First IDSA Guidelines on Complicated UTIs

Clinical Pharmacy

Chronic Graft-Versus-Host Disease (cGVHD)

cGVHD differs fundamentally from acute GVHD and resembles features of autoimmunity and chronic inflammation-driven fibrosis. The pathogenesis includes three overlapping phases.

Clinical Pharmacy

Chagas Disease: A Deadly "Kiss"

Chagas disease, caused by Trypanosoma cruzi, is a serious parasitic infection often overlooked in non-endemic areas, with rising U.S. cases. Join us for this week's discussion on this topic!

Health and Wellness

L-Theanine: An Effective Anxiolytic and Focus-enhancing Supplement?

L-theanine is a naturally occurring amino acid that has been generating buzz for its proposed anxiolytic, focus-enhancing, and sleep-improving effects!